Senior insider sale
Chief Financial Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$280.0K
6.80K shares
What this filing means
SCHILKE TOBIN plans to sell 6.80K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $280.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001628280-26-013047
Officer· Chief Financial Officer
Since Mar 2026
6.80K
Shares to sell
$280.0K
Approx. market value
13K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
3/1/2026
13KTotal acquired13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | Restricted Stock Unit Vesting Compensation | 13K | — |
| Total | 13K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
6.80K
Market value
$280.0K
3/2/2026
Total
Units
6.80K
Value
$280.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/2/2026 | 6.80K | $280.0K | Nasdaq | Planned |
| Total | 6.80K | $280.0K | ||